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EDITORIAL
Shiga toxin-induced tubular injury in hemolytic uremic syndrome
To conform with a proposed new terminology for the
shiga-like toxin (Stx) family [1], we use the term Shiga
toxin-associated hemolytic uremic syndrome (Stx HUS) for
cases caused by Stx-producing bacteria [2]; however, diar-
rhea-associated HUS (D1 HUS) and Stx HUS are still
used interchangeably. Stx HUS is a well-defined clinico-
pathologic entity in which acute renal injury is usually the
major component. Stx HUS is a complication of Stx-
producing E. coli, usually but not always, serotype 0157:H7
and Shigella dysenteriae type 1. Patients with Stx HUS may
have normal urine output. More often they may be anuric
or oliguric and some may have non-oliguric renal failure
[3]. There is abundant clinical, pathophysiologic and his-
topathologic evidence for glomerular endothelial cell injury
in Stx HUS. Renal tubular injury has been considered to be
secondary to glomerular and arteriolar injury in Stx HUS.
However, evidence for direct renal tubular cell damage in
Stx HUS is increasing [4–7].
In HUS caused by Shigella dysenteriae type I, there are
glomerular injury and fibrin thrombi. However, in 1978
Raghupathy et al noted that there were also histopatho-
logic changes of acute tubular necrosis manifested by
tubular epithelial shedding, casts, interstitial edema, inter-
stitial inflammation at the cortico-medullary junction and
mononuclear cells in the vasa rectae [8]. It is of historical
interest that the title of what may have been the first
reported case of HUS, in 1954, was Acute Tubular Necrosis
with Anaemia [9]. The four-year-old patient presented with
vomiting and watery diarrhea with blood and mucus com-
plicated by acute hemolytic anemia, thrombocytopenia,
acute renal failure and seizures [9].
Evidence for primary renal tubular cell damage in Stx
HUS has been derived mainly from in vitro and in vivo
studies in animals [4–7]. Takeda et al showed that human
adenocarcinoma cells of renal tubular origin were highly
sensitive to Stx1 and Stx2 [4]. They also found significantly
increased urine concentrations of N-acetyl glucosaminidase
and b2 microglobulin in patients with Stx HUS [4]. This
pointed to renal tubular injury but did not provide convinc-
ing evidence for a direct effect of Stx on the tubules.
Induction of medullary renal tubular injury by Stx in an
isolated perfused rat kidney model was more compelling
evidence for a direct effect of Stx on the renal tubule [5].
Hughes et al have studied the effects of Stx1 on human
proximal tubule cells in vitro and have provided additional
compelling evidence to support the hypothesis that Stx
directly injures these cells [10]. Their findings complement
those of others [4–7]. Human renal tubular cells undergo
apoptosis in vivo following D1 HUS and in an in vivo
mouse model of E. coli-associated HUS [6]. Apoptosis was
also shown in human adenocarcinoma-derived renal tubu-
lar epithelial cells [7]. In these models the effect of Stx is
enhanced by tumor necrosis factor-a (TNF-a) [6,7].
Hughes et al have found that Stx1 binds to receptors and
injures the proximal renal tubular cells [10]. Incubation
with interleukin-1 (IL-1) enhanced the cytotoxic effect of
Stx1 and lipopolysaccharide increased cell sensitivity to Stx
without altering Stx binding. Neither IL-6 nor TNF-a had
any effects. A similar cascade of effects has been found in
human renal endothelial cells. Learning how Stx is able to
pass through the glomerular capillary wall in order to reach
the tubular epithelial cells will add considerably to under-
standing the biology of Stx-induced renal injury.
These findings suggest that the oligo-anuria that occurs
in many of these patients, and the non-oliguric renal failure
that occur in some [3] may not be the result of glomerular
and vascular injury alone. These observations may help to
differentiate Stx HUS more precisely from other types of
HUS such as malignancy-associated HUS, inherited HUS,
and atypical D2 HUS, and from thrombotic thrombocyto-
penic purpura. Taken together, these studies add consider-
ably to our understanding of the pathogenesis of acute
renal injury in Stx HUS. These findings do not, as yet,
change the treatment or prognosis of this entity.
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